Edward J. Bataillard
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Early PET response predicts the risk of relapse after 2L axi-cel in large B-cell lymphoma.
Journal: Blood advances
Published: January 21, 2026
Early PET response predicts the risk of relapse after 2L axi-cel in large B-cell lymphoma.
Journal: Blood advances
Published: January 21, 2026
Outcomes of second-line axicabtagene ciloleucel for large B-cell lymphoma in the UK.
Journal: HemaSphere
Published: September 05, 2025
TRAIL Score: A Simple Model to Predict Immunochemotherapy Tolerability in Patients With Diffuse Large B-Cell Lymphoma.
Journal: JCO clinical cancer informatics
Published: January 19, 2022
Ruxolitinib for tocilizumab-refractory severe COVID-19 infection.
Journal: British journal of haematology
Published: June 28, 2020
No longer any role for routine follow-up chest x-rays in men with stage I germ cell cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: April 20, 2017
Lesson of the month 2: Non-uraemic calciphylaxis - an unexpected differential diagnosis for a necrotic ulcer.
Journal: Clinical medicine (London, England)
Published: December 02, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026